Former U.S. President Bill Clinton and drugmakers Pfizer and Matrix Laboratories Ltd announced a deal on Thursday to lower the cost of treatments for patients with drug-resistant forms of HIV/AIDS.
Second-line antiretroviral therapies and a drug used to treat tuberculosis for those with drug-resistant HIV/AIDS will be made available at a reduced cost and in more convenient regimens, saving as many as hundreds of thousands of lives in the developing world.
Cases of cyclosporiasis, a parasitic infection known for causing explosive diarrhea, have now reached 47 states...
Robert F Kennedy Jr, the US health secretary, on Sunday told American parents that they should...
Within months of being soaked with a glyphosate herbicide while working on a cell tower maintenance...
